Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
International Journal of Molecular Sciences|October 27, 2022
The Effects of Genistein at Different Concentrations on <i>MCF-7</i> Breast Cancer Cells and <i>BJ</i> Dermal FibroblastsMagda Aleksandra Pawlicka, Szymon Zmorzyński, Sylwia Popek-Marciniec, et al.Medical Oncology (Northwood, London, England)|August 4, 2019
Examination of clonal evolution in chronic lymphocytic leukemiaDorota Koczkodaj, Sylwia Popek-Marciniec, Szymon Zmorzyński, et al.Clinical Neurology and Neurosurgery|October 22, 2019
Non-traumatic cervical artery dissection and ischemic stroke: A narrative review of recent researchMichał Marciniec, Klaudia Sapko, Marcin Kulczyński, et al.Reviews in the Neurosciences|March 28, 2019
Pain in cervical dystonia and the antinociceptive effects of botulinum toxin: what is currently known?Michał Marciniec, Anna Szczepańska-Szerej, Marcin Kulczyński, et al.Journal of Clinical Medicine|April 12, 2022
<i>WT1</i> Gene Mutations, rs16754 Variant, and <i>WT1</i> Overexpression as Prognostic Factors in Acute Myeloid Leukemia PatientsDorota Koczkodaj, Szymon Zmorzyński, Beata Grygalewicz, et al.Journal of Clinical Medicine|November 27, 2021
The Relationship of <i>ABCB1/MDR1</i> and <i>CYP1A1</i> Variants with the Risk of Disease Development and Shortening of Overall Survival in Patients with Multiple MyelomaSzymon Zmorzynski, Magdalena Wojcierowska-Litwin, Sylwia Popek-Marciniec, et al.Acta Haematologica|April 4, 2023
CCL3 as Possible Negative Prognostic Factor in Chronic Lymphocytic LeukemiaSylwia Popek-Marciniec, Szymon Zmorzyński, Dorota Koczkodaj, et al.Genes|March 28, 2024
In Vitro Low-Bortezomib Doses Induce Apoptosis and Independently Decrease the Activities of Glutathione S-Transferase and Glutathione Peroxidase in Multiple Myeloma, Taking into Account the <i>GSTT1</i> and <i>GSTM1</i> Gene VariantsSzymon Zmorzynski, Sylwia Popek-Marciniec, Beata Biernacka, et al.Journal of Clinical Medicine|March 29, 2023
The Relationship of <i>CCL5</i> and <i>CCR1</i> Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple MyelomaSylwia Popek-Marciniec, Wojciech Styk, Magdalena Wojcierowska-Litwin, et al.Frontiers in Oncology|March 21, 2025
Associations of ANGPT2 expression and its variants (rs1868554 and rs7825407) with multiple myeloma risk and outcomeSylwia Popek-Marciniec, Wojciech Styk, Sylwia Chocholska, et al.Pageof 2